-
50+Automated synthesis of radioactive drugs
-
Dual acceleratorSeparation and purification of nuclides
-
Radiolabeling yield >95%
-
Compliant with GMP Production standards
Product Details
With its unique ready-to-use cassette-based design and pre-loaded reagents, the system ensures regulatory compliance and reliability throughout the tracer production process.
-
Easily improve daily productivity
The Mortenon M1 enables automated synthesis of over 50 radiopharmaceuticals and can be used for the production of innovative tracers in research and clinical settings. Up to four modules can be installed within a single hot cell, maximizing space utilization and enabling an integrated solution focused on radiopharmaceutical synthesis with supplementary radionuclide processing—while significantly reducing manual intervention. Ready-to-use protocols are pre-installed, including universal synthesis programs for ⁶⁸Ga, ⁸⁹Zr, ⁶⁴Cu, and ¹⁷⁷Lu, along with dozens of validated tracer synthesis workflows, which can be directly selected for use.
-
Supports Extended Functions Beyond Radiopharmaceutical Synthesis
Compatible with both solid and liquid targets, the system meets the purification needs of accelerator-produced metallic radionuclides without requiring additional purification modules.
It enables automated elution of various radionuclide generators and supports portioning based on batch synthesis requirements. The system can transfer radionuclides to other hot cells, eliminating manual elution or bulk radionuclide handling—significantly improving operational efficiency and radiation safety.
-
Single-Use Cassette: Safe and Efficient
Provides Cassettes for Over 50 Radiopharmaceuticals Achieves ≥89% yield for 89Zr, ≥65% for 64Cu, and ≥55% for 68Ga. The fluid pathways are completely isolated from the main unit through single-use disposable cassettes. After cassette replacement, no radioactive residue remains in the main unit, effectively preventing cross-contamination between batches. This design is particularly suitable for labeling with long half-life radionuclides.
-
Remote Operation via Software System
Synthesis operations can be performed remotely through the software system without the need to open the hot cell. The system complies with 21 CFR Part 11 regulatory requirements, featuring automatic data recording, complete audit trails, and full traceability throughout the process, while ensuring the integrity of printed records. Users can also drag and drop interface elements to create customized workflows.
Its intuitive visual editor allows users to easily create customized workflows. All synthesis processes are automatically documented to ensure full traceability, simplifying monitoring and data retention.
Product portfolio
Customer Reviews
A radiopharmaceutical startup company
Thanks to the seamless integration of the Mortenon M1 automated synthesis module with its single-use cassette system, our laboratory is able to efficiently carry out consecutive syntheses of multiple radiopharmaceuticals, fully supporting the company's development of novel tracers. The system delivers stable yields and reliable performance.
We have successfully produced multiple batches of 68Ga- and 177Lu-labeled radiopharmaceuticals targeting urologic tumors to meet the supply needs for Phase I/II clinical studies.
A tertiary referral hospital
Radiopharmaceuticals are the foundation of molecular imaging in nuclear medicine and precision diagnosis and therapy. They are the result of the integrated interaction among radionuclides, targeting molecules, and automated synthesis equipment. The diversified, specific, high-quality, and highly stable synthesis and supply of radiopharmaceuticals play a critical role in ensuring the smooth operation of PET centers.
Mortenon Smart
Mortenon M1 boasts powerful capabilities. Its functions for radionuclide dispensing and purification have significantly reduced procurement costs for hospitals. In terms of drug synthesis, beyond the conventional small molecules and peptides, the system also enables fully automated antibody labeling, delivering high yields with stable performance. This greatly expands the variety of compounds that can be synthesized while minimizing radiation exposure for medical staff.
Additionally, the equipment is compliant with GMP production standards. Through customizable programs and tailor-made cassettes, it supports process development. In our research, we have already developed various synthesis processes on the module. This has broadened the range of in-hospital tumor diagnostics and enhanced the department's overall capabilities.
Q&A
-
Can the Mortenon M1 accommodate customized workflows from partners?
The Mortenon M1 was designed from the outset with a strong emphasis on scalability and compatibility. We support co-development with partners to create customized cassettes and synthesis protocols, ensuring the system maintains high technical adaptability and forward compatibility throughout product iteration cycles. In other words, the Mortenon M1 is not just an automated device — it is a future-ready, continuously evolving platform for radiopharmaceutical production. -
What does the after-sales service for Mortenon M1 include?We provide comprehensive after-sales services for the Mortenon M1, including equipment installation and commissioning, operator training, regular maintenance, troubleshooting, and remote technical support. Additionally, spare parts are supplied promptly to ensure stable and worry-free operation. Our service team responds quickly, and users can contact us anytime via hotline, email, or other channels. We will arrange timely support based on the situation to ensure the equipment runs efficiently and reliably.
